Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Novelion Therapeutics Inc.

TRADE

NASDAQ: NVLNHealthcare / Biotechnology / Canada
0.88+0.03+3.53%Vol 128 9811Y Perf -80.41%
Nov 21st, 2018 10:31
BID0.88 ASK0.89
Open0.96 Previous Close0.86
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.50 
Analyst Rating
Hold 3.00
Potencial %
622.22 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
+     35.82
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     35.79
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Price Range Ratio 52wk %
3.48 
Earnings Date

Today's Price Range

0.870.96

 

52wk Range

0.705.87

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-17.48%
3 Months
-72.31%
6 Months
-81.07%
1 Year
-80.41%
3 Years
-93.73%
5 Years
-96.71%

Quotes

Name / TickerPriceChg.Chg.%
NVLN0.880.03003.53
AAPL178.091.11000.63
GOOG1 043.2517.49001.71
MSFT103.531.82001.79
XOM77.670.70000.91
WFC53.060.52000.99
JNJ142.87-3.5800-2.44
FB136.233.80002.87
GE7.870.22002.88
JPM109.200.75000.69
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.10
Current Ratio 0.20
Long Term Debt to Total Capital 0.95
Total Debt to Equity 17.31
Interest Coverage -4.30
Leverage Ratio -12.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin54.30
EBIT Margin-48.90
EBITDA Margin-27.90
Pre-tax Profit Margin-
Profit Margin-88.21
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.86
PS Ratios 0.11
Price to Cash Flow 33.10
Price to Free Cash Flow -3.10
Cash Flow Per Share -4.72
Price to Tangible Book-0.71
Book Value per Share-3.65
Enterprise Value (in ths.)294 573
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-29.19
ROE last 12 Months 733.91
Return on Assets (5Y Avg) -12.63
ROA last 12 Months -30.95
Return on Capital (5Y Avg) -16.33
ROC last 12 Months -48.02
Return on invested Capital Q -8.08
Return on invested Capital Y-39.92
Assets Turnover0.10
Receivables Turnover1.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)128 630
Revenue per Share 8.92
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--1.32-
Q02 2018--0.64-
Q01 2018--1.76-
Q04 2017-1.58-1.3216.46
Q03 2017-0.29-0.89-206.90
Q02 2017-0.09-0.13-44.44
Q01 2017-0.47-0.54-14.89
Q04 2016-0.50-1.76-252.00
Earnings Per EndEstimateRevision %Trend
12/2017 QR-2.23-36.81Negative
12/2018 QR-0.9085.44Positive
12/2018 FY-5.6311.34Positive
12/2019 FY-3.64--
Next Report Date8th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume128 981
Shares Outstanding (in ths.)18 930
Trades Count140
Dollar Volume104 953
Avg. Volume563 225
Avg. Weekly Volume1 091 762
Avg. Monthly Volume4 690 146
Avg. Quarterly Volume1 812 237

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

62%38%

Bearish Bullish

38%62%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
1 (100.00 %)
1 (100.00 %)
Hold
1 (100.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News

x